au-racgp MCQ (SBA): Glycaemic targets in type 2 diabetes

Instant feedback + full explanation. One question, done properly.

MediumEndocrinologyGlycaemic targets in type 2 diabetesau-racgpau-racpau-amc

A 62-year-old man with type 2 diabetes for 10 years and ischaemic heart disease has an HbA1c of 6.4% (46 mmol/mol) on metformin and an SGLT2 inhibitor. He has occasional mild hypoglycaemic symptoms. According to Australian type 2 diabetes guidance, which HbA1c target is generally appropriate for a patient like him?

Educational content. Not a substitute for clinical judgement or local policy.